OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-03-31-accounts

Digitally Signed Document Document ID: 4728509171E5F7

Document Details

MUL-001-Charity accounts (draft)-SAMROB- Filename: 20250926-174237-916.PDF ~~= UlUlt~—~~ Client of: Connolly Accountants & Business Advisors Ltd ~~== +~~ Signature Details Name: Janet Bohn ~~<<~~ Email: mktherapycentre@outlook.com ~~<<~~ Date & Time: 15/10/2025 16:24:40 PM (BST) ~~<<~~ IP Address: 90.196.214.94 ~~<<~~ Janet Bohn agrees and approves the contents of Signing Statement: this document. ~~ee~~

Digital Certificate

The approved PDF file has been digitally certified.Please check the Digital Certificate information in your PDF viewer to verify the Digital Certificate authenticity and the PDF has not been tampered with.

On behalf of: Connolly Accountants & Business Advisors Ltd ~~<<~~ PDF digital certificate: IRIS Software Group Limited ~~<<~~ Digital certificate issued by: GlobalSign ~~=~~

Please keep a copy of this document for your records.

REGISTERED COMPANY NUMBER: 02791056 (England and Wales) REGISTERED CHARITY NUMBER: 1017488

Report of the Trustees and

Unaudited Financial Statements

for the Year Ended 31 March 2025

for

M.K. Multiple Sclerosis Therapy Group Limited

Connolly Accountants & Business Advisors Ltd Chartered Certified Accountants

The Stable Yard 25-33 Vicarage Road Stony Stratford Milton Keynes Buckinghamshire MK11 1BN

M.K. Multiple Sclerosis Therapy Group Limited

Contents of the Financial Statements FOR THE YEAR ENDED 31 MARCH 2025

Page
Report of the Trustees 1 to 2
Independent Examiner's Report 3
Statement of Financial Activities 4
Balance Sheet 5 to 6
Notes to the Financial Statements 7 to 12
Detailed Statement of Financial Activities 13 to 14

M.K. Multiple Sclerosis Therapy Group Limited

Report of the Trustees FOR THE YEAR ENDED 31 MARCH 2025

Trustee report for year ended 31st March 2025

The trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31st March 2025. The trustees have adopted the provisions of the Charities (SORP) FRS102 'Accounting and Reporting by Charities' (effective 1st January 2015).

Principal Activity

The Company was incorporated to provide relief to sufferers of Multiple Sclerosis from a permanent base in Milton Keynes. (MKMSTG) We also treat other conditions such as Fibromyalgia, Parkinson's, Arthritis, Cancer, Cerebral Palsy (CP), Autism, Long Covid and Sports Injury. Funds for the upkeep of the centre are generated by payment for treatment, fund raising, sponsorship, donations, subscription and grants.

Review of activities

The financial year April 2024 to March 2025 has been a busy year for the Therapy Centre. Membership has been growing steadily throughout the year but it has been noticeable that members with other conditions have overtaken those with Multiple Sclerosis particularly those having Hyper-baric Oxygen Therapy.

In May 2024 we celebrated our 31st year anniversary for MKMSTG with a very successful Open Day. Many people came to help us celebrate with a mixture of members, supporters, health professionals and local dignitaries. The Mayors of Milton Keynes and Wolverton attended.

In October we held our Annual General Meeting to present the yearly accounts to members. The Trustees were pleased that most of the Committee were voted back to continue volunteering as Operators and Committee members. Our long standing Secretary Sheila Stockton decided not to stand for re-election this year. However, Sheila will continue helping with new member's paperwork, running the website, being our IT expert and helping the Centre Manager with many other administrative jobs.

Two of our long standing volunteers agreed to join the Board of Trustees, Mrs Chris Warburton and Mrs Claire Boreham Hill. This brings the number of Trustees to four.

In December we held our annual mincepie morning with a Christmas raffle. It was very well attended by volunteers and members. Thank you to all who kindly provided us with some really great prizes.

The state of the building and the subsidence is still being monitored by the Insurers and the Agent Kirkby Diamond on behalf of Landlords, MK Community Foundation.

Operating Income

Operating income for this accounting period (which includes payments and subscriptions) was £38,692 almost the same as last year. Donations/fundraising was £3,695 slightly up on last year. Our thanks to Ontario Ladies Choir, The Lenborough Singers, Lions Club, Robert Stanley, Oddfellows and our generous members. Total Income was £43,379, Expenditure was £53,744. During this financial year some utilities were particularly high. Fortunately, our Centre Manager Sharn was able to negotiate new contracts which have significantly reduced the size of current, and hopefully future, invoices. At the end of the year we transferred £4000 from the Building fund at the Coventry building Society, to cover bills due at the end of December. The total of the Building fund now stands at £98,165 before interest. The Treasurer hopes to replace this transfer during 2025.

The Trustees would like to thank the Centre Manager, Sharn Nandhra, The Committee and Chair Chris Warburton, Secretary Caroline Musgrove, Volunteer Operators and Therapists for their work, dedication and help in continuing to keep the MK MS Therapy Centre open and operating safely. We continue providing much needed therapies for our members within the local community and wider area. Our thanks also go to our Patron, Dr Fernandes and the Management team, for their continued dedication and support.

The Trustees would also like to thank Sheila Stockton for her support as a Committee member and Secretary.

1

M.K. Multiple Sclerosis Therapy Group Limited

Report of the Trustees FOR THE YEAR ENDED 31 MARCH 2025

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee as defined by the Companies Act 2006.

The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error.

REFERENCE AND ADMINISTRATIVE DETAILS

Registered Company number

02791056 (England and Wales)

Registered Charity number

1017488

Registered office

4 Hollin Lane Stacey Bushes Milton Keynes Buckinghamshire MK12 6HT

Trustees

Ms R Heredia Managing Director Ms J Bohn Company Secretary

Company Secretary

Ms J Bohn

Independent Examiner

Declan Connolly FCCA Connolly Accountants & Business Advisors Ltd Chartered Certified Accountants The Stable Yard 25-33 Vicarage Road Stony Stratford Milton Keynes Buckinghamshire MK11 1BN

This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

Approved by order of the board of trustees on 20 October 2025 and signed on its behalf by:

Ms R Heredia - Trustee

2

Independent Examiner's Report to the Trustees of M.K. Multiple Sclerosis Therapy Group Limited

Independent examiner's report to the trustees of M.K. Multiple Sclerosis Therapy Group Limited ('the Company')

I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2025.

Responsibilities and basis of report

As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.

Independent examiner's statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

  1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or

  4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Declan Connolly FCCA

Connolly Accountants & Business Advisors Ltd Chartered Certified Accountants The Stable Yard 25-33 Vicarage Road Stony Stratford Milton Keynes Buckinghamshire MK11 1BN

Date: .............................................

3

M.K. Multiple Sclerosis Therapy Group Limited

Statement of Financial Activities FOR THE YEAR ENDED 31 MARCH 2025

Unrestricted
funds
Notes
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
43,285
Other trading activities
2
95
Investment income
3
2,895
Total
46,275
EXPENDITURE ON
Raising funds
4
28,722
Charitable activities
Fundraising
24,841
Other
-
Total
53,563
NET INCOME/(EXPENDITURE)
(7,288)
RECONCILIATION OF FUNDS
Total funds brought forward
112,465
TOTAL FUNDS CARRIED FORWARD
105,177		 Restricted
fund
£
-
-
-
-
-
182
-
182
(182)
3,083
2,901		 2025
Total
funds
£
43,285
95
2,895
46,275
28,722
25,023
-
53,745
(7,470)
115,548
108,078		 2024
Total
funds
£
77,818
72
2,375
80,265
40,391
16,499
720
57,610
22,655
92,893
115,548

The notes form part of these financial statements

4

M.K. Multiple Sclerosis Therapy Group Limited

Balance Sheet 31 MARCH 2025

Unrestricted
funds
Notes
£
FIXED ASSETS
Tangible assets
9
162
CURRENT ASSETS
Debtors
10
2,303
Cash at bank and in hand
103,594
105,897
CREDITORS
Amounts falling due within one year
11
(882)
NET CURRENT ASSETS
105,015
TOTAL ASSETS LESS CURRENT
LIABILITIES
105,177
NET ASSETS
105,177
FUNDS
13
Unrestricted funds:
General fund
Restricted funds:
General Fund Restricted
TOTAL FUNDS		 Restricted
fund
£
181
-
2,720
2,720
-
2,720
2,901
2,901		 2025
Total
funds
£
343
2,303
106,314
108,617
(882)
107,735
108,078
108,078
105,177
2,901
108,078		 2024
Total
funds
£
834
2,119
113,426
115,545
(831)
114,714
115,548
115,548
112,465
3,083
115,548

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The trustees acknowledge their responsibilities for

The notes form part of these financial statements

5

continued...

M.K. Multiple Sclerosis Therapy Group Limited

Balance Sheet - continued 31 MARCH 2025

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.

The financial statements were approved by the Board of Trustees and authorised for issue on 20 October 2025 and were signed on its behalf by:

R Heredia - Trustee

J Bohn - Trustee

The notes form part of these financial statements

6

M.K. Multiple Sclerosis Therapy Group Limited

Notes to the Financial Statements FOR THE YEAR ENDED 31 MARCH 2025

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery - 25% on cost Fixtures and fittings - 3 years Computer equipment - 3 years

Taxation

The charity is exempt from corporation tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to the Statement of Financial Activities on a straight line basis over the period of the lease.

continued...

7

M.K. Multiple Sclerosis Therapy Group Limited

Notes to the Financial Statements - continued FOR THE YEAR ENDED 31 MARCH 2025

2.
OTHER TRADING ACTIVITIES
Shop sales income
3.
INVESTMENT INCOME
Deposit account interest
4.
RAISING FUNDS
Raising donations and legacies
Rent
Rates and water
Insurance
Light and heat
Telephone
Postage and stationery
HBO costs
Fund raising - raffle
Fundraising
Support costs
5.
NET INCOME/(EXPENDITURE)
Net income/(expenditure) is stated after charging/(crediting):
Depreciation - owned assets
Rent		 2025
£
95
2025
£
2,895
2025
£
5,825
113
2,334
3,808
954
439
12,306
-
86
-
25,865
2025
£
491
5,825		 2024
£
72
2024
£
2,375
2024
£
5,205
495
2,115
4,922
739
234
9,152
11
4,593
9,271
36,737
2024
£
664
5,205

6. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 March 2025 nor for the year ended 31 March 2024.

Trustees' expenses

There were no trustees' expenses paid for the year ended 31 March 2025 nor for the year ended 31 March 2024.

continued...

8

M.K. Multiple Sclerosis Therapy Group

Limited

Notes to the Financial Statements - continued FOR THE YEAR ENDED 31 MARCH 2025

7. STAFF COSTS

The average monthly number of employees during the year was as follows:

8.

Trustees
No employees received emoluments in excess of £60,000.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
funds
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
75,098
Other trading activities
72
Investment income
2,375
Total
77,545
EXPENDITURE ON
Raising funds
40,210
Charitable activities
Fundraising
16,499
Other
720
Total
57,429
NET INCOME
20,116
RECONCILIATION OF FUNDS
Total funds brought forward
92,349
TOTAL FUNDS CARRIED FORWARD
112,465		 2025
4
Restricted
fund
£
2,720
-
-
2,720
181
-
-
181
2,539
544
3,083		 2024
2
Total
funds
£
77,818
72
2,375
80,265
40,391
16,499
720
57,610
22,655
92,893
115,548

continued...

9

M.K. Multiple Sclerosis Therapy Group Limited

Notes to the Financial Statements - continued FOR THE YEAR ENDED 31 MARCH 2025

9. TANGIBLE FIXED ASSETS

Fixtures
Plant and
and
machinery
fittings
£
£
COST
At 1 April 2024 and 31 March 2025
48,408
22,947
DEPRECIATION
At 1 April 2024
48,046
22,944
Charge for year
181
3
At 31 March 2025
48,227
22,947
NET BOOK VALUE
At 31 March 2025
181
-
At 31 March 2024
362
3
10.
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Prepayments
11.
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Accrued expenses
12.
LEASING AGREEMENTS
Minimum lease payments under non-cancellable operating leases fall due as follows:
Within one year
13.
MOVEMENT IN FUNDS
At 1.4.24
£
Unrestricted funds
General fund
112,465
Restricted funds
General Fund Restricted
3,083
TOTAL FUNDS
115,548		 Computer
equipment
£
2,271
1,802
307
2,109
162
469
2025
£
2,303
2025
£
882
2025
£
6,447
Net
movement
in funds
£
(7,288)
(182)
(7,470)		 Totals
£
73,626
72,792
491
73,283
343
834
2024
£
2,119
2024
£
831
2024
£
5,247
At
31.3.25
£
105,177
2,901		 Totals
£
73,626		 Totals
£
73,626
72,792
491
73,283
343
834
2024
£
2,119
2024
£
831
2024
£
5,247
108,078

continued...

10

M.K. Multiple Sclerosis Therapy Group

Limited

Notes to the Financial Statements - continued FOR THE YEAR ENDED 31 MARCH 2025

13. MOVEMENT IN FUNDS - continued

Net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
General fund 46,275 (53,563) (7,288)
Restricted funds
General Fund Restricted - (182) (182)
TOTAL FUNDS 46,275 (53,745) (7,470)
Comparatives for movement in funds
Net
movement At
At 1.4.23 in funds 31.3.24
£ £ £
Unrestricted funds
General fund 92,349 20,116 112,465
Restricted funds
General Fund Restricted 544 2,539 3,083
TOTAL FUNDS 92,893 22,655 115,548
Comparative net movement in funds, included in the above are as follows:
Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
General fund 77,545 (57,429) 20,116
Restricted funds
General Fund Restricted 2,720 (181) 2,539
TOTAL FUNDS 80,265 (57,610) 22,655

continued...

11

M.K. Multiple Sclerosis Therapy Group Limited

Notes to the Financial Statements - continued FOR THE YEAR ENDED 31 MARCH 2025

13. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined position is as follows:

Unrestricted funds
General fund
Restricted funds
General Fund Restricted
TOTAL FUNDS		 At 1.4.23
£
92,349
544
92,893		 Net
movement
in funds
£
12,828
2,357
15,185		 At
31.3.25
£
105,177
2,901
108,078

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
General fund 123,820 (110,992) 12,828
Restricted funds
General Fund Restricted 2,720 (363) 2,357
TOTAL FUNDS 126,540 (111,355) 15,185

14. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 March 2025.

12

M.K. Multiple Sclerosis Therapy Group Limited

Detailed Statement of Financial Activities FOR THE YEAR ENDED 31 MARCH 2025

FOR THE YEAR ENDED 31 MARCH 2025
2025 2024
£ £
INCOME AND ENDOWMENTS
Donations and legacies
Donations general 1,768 4,165
Operating income 38,692 42,238
Fund raising 1,928 30,423
Other income 897 992
43,285 77,818
Other trading activities
Shop sales income 95 72
Investment income
Deposit account interest 2,895 2,375
Total incoming resources 46,275 80,265
EXPENDITURE
Raising donations and legacies
Rent 5,825 5,205
Rates and water 113 495
Insurance 2,334 2,115
Light and heat 3,808 4,922
Telephone 954 739
Postage and stationery 439 234
HBO costs 12,306 9,152
Fund raising - raffle - 11
Fundraising 86 4,593
25,865 27,466
Other trading activities
Purchases 460 360
Cleaning 2,397 3,263
2,857 3,623
Charitable activities
Therapist costs 15,723 15,969
Subscriptions 320 530
16,043 16,499
Other
Training - 720
Support costs

This page does not form part of the statutory financial statements

13

M.K. Multiple Sclerosis Therapy Group Limited

Detailed Statement of Financial Activities FOR THE YEAR ENDED 31 MARCH 2025

2025 2024
£ £
Support costs
Management
Maintenance 1,474 2,269
Office manager 5,998 5,512
Plant and machinery 182 181
Fixtures and fittings 3 95
Computer equipment 307 387
7,964 8,444
Finance
Bank charges 134 31
Governance costs
Accountancy and legal fees 882 827
Total resources expended 53,745 57,610
Net (expenditure)/income (7,470) 22,655

This page does not form part of the statutory financial statements

14